N. Davidson

2.4k total citations · 1 hit paper
41 papers, 1.9k citations indexed

About

N. Davidson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, N. Davidson has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in N. Davidson's work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (6 papers). N. Davidson is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (6 papers). N. Davidson collaborates with scholars based in United Kingdom, United States and Netherlands. N. Davidson's co-authors include Nigel Bundred, Antonio Llombart‐Cussac, Gϋnter von Minckwitz, Robert L. Coleman, Holger Eidtmann, Martin Gore, Richard de Boer, Robert E. Coleman, Anderley Gordon and C Scarabelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

N. Davidson

41 papers receiving 1.8k citations

Hit Papers

Topotecan versus paclitaxel for the treatment of recurren... 1997 2026 2006 2016 1997 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
    1997 532 citations Martin Gore, N. Davidson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Davidson United Kingdom 15 1.3k 501 439 358 357 41 1.9k
Patrick Berteloot Belgium 25 741 0.6× 458 0.9× 821 1.9× 220 0.6× 347 1.0× 88 2.0k
Michela Donadio Italy 23 1.1k 0.8× 258 0.5× 85 0.2× 352 1.0× 330 0.9× 68 1.8k
Mark George United Kingdom 16 649 0.5× 387 0.8× 74 0.2× 410 1.1× 157 0.4× 33 1.5k
George Omura United States 18 619 0.5× 591 1.2× 832 1.9× 532 1.5× 234 0.7× 52 2.5k
Giuseppe Badalamenti Italy 25 1.0k 0.8× 441 0.9× 58 0.1× 621 1.7× 764 2.1× 144 2.3k
Samantha Pozzi Italy 27 1.1k 0.9× 108 0.2× 62 0.1× 853 2.4× 201 0.6× 91 2.3k
Re G Italy 20 823 0.6× 295 0.6× 61 0.1× 513 1.4× 576 1.6× 96 1.6k
Annette Fisseler‐Eckhoff Germany 22 472 0.4× 324 0.6× 139 0.3× 254 0.7× 631 1.8× 92 1.5k
B. Massidda Italy 23 1.6k 1.2× 292 0.6× 63 0.1× 302 0.8× 848 2.4× 84 2.3k
Beyhan Ataseven Germany 29 935 0.7× 593 1.2× 752 1.7× 372 1.0× 367 1.0× 124 2.3k

Countries citing papers authored by N. Davidson

Since Specialization
Citations

This map shows the geographic impact of N. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Davidson more than expected).

Fields of papers citing papers by N. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Davidson. The network helps show where N. Davidson may publish in the future.

Co-authorship network of co-authors of N. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of N. Davidson. A scholar is included among the top collaborators of N. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Davidson. N. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Battisti, Nicolò Matteo Luca, Belinda Kingston, James P. King, et al.. (2019). Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience. Cancer Research. 79(4_Supplement). P6–18. 1 indexed citations
2.
Coleman, Robert E., Richard de Boer, Holger Eidtmann, et al.. (2012). Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Annals of Oncology. 24(2). 398–405. 258 indexed citations
3.
Eidtmann, Holger, Richard de Boer, Nigel Bundred, et al.. (2010). Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Annals of Oncology. 21(11). 2188–2194. 229 indexed citations
4.
5.
Wardley, Andrew, N. Davidson, Peter Barrett‐Lee, et al.. (2005). Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. British Journal of Cancer. 92(10). 1869–1876. 121 indexed citations
6.
Fox, David L., Sanjiv Petkar, N. Davidson, & Anne M. Fitzpatrick. (2005). Biventricular pacing in a patient with ventilatory and inotropic dependant heart failure following coronary artery by-pass surgery. EP Europace. 7(5). 490–491. 8 indexed citations
7.
Chan, Stephen, N. Davidson, Elona Juozaitytė, et al.. (2004). Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer. Annals of Oncology. 15(10). 1527–1534. 114 indexed citations
8.
Skovsgaard, Torben, N. Davidson, Martine Piccart, et al.. (2001). A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer. Annals of Oncology. 12(9). 1255–1257. 11 indexed citations
9.
10.
11.
12.
Davidson, N.. (1996). Single-agent paclitaxel as first-line treatment of metastatic breast cancer: the British experience.. PubMed. 23(5 Suppl 11). 6–10. 31 indexed citations
13.
Cunningham, David, et al.. (1993). The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer. European Journal of Cancer. 29(3). 303–306. 24 indexed citations
14.
Soukop, M., B. McQuade, Alan L. Stewart, et al.. (1992). Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer. Oncology. 49(4). 295–304. 69 indexed citations
15.
Davidson, N., et al.. (1991). Oral cavity metastasis from carcinoma of the cervix. International Journal of Gynecology & Obstetrics. 35(1). 79–82. 10 indexed citations
16.
Davidson, N., et al.. (1991). Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary. Clinical Oncology. 3(1). 32–36. 10 indexed citations
17.
Davidson, N.. (1990). Tracheal infiltration causing stridor: a rare presentation of Stage I Hodgkin's disease. International Journal of Clinical Practice. 44(12). 676–678. 3 indexed citations
18.
Davidson, N., et al.. (1990). Oesophageal Carcinoma Following Internal Mammary Chain Irradiation for Carcinoma of the Breast—a Report of Six Cases. Acta Oncologica. 29(8). 1059–1060. 11 indexed citations
19.
Davidson, N., et al.. (1990). Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary. Clinical Oncology. 2(4). 206–209. 2 indexed citations
20.
Kensler, Thomas W., et al.. (1976). Aflatoxin inhibition of glucocorticoid binding capacity of rat liver nuclei. Biochimica et Biophysica Acta (BBA) - General Subjects. 437(1). 200–210. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Berteloot Breakdown of academic impact, for papers by Michela Donadio Breakdown of academic impact, for papers by Mark George Breakdown of academic impact, for papers by George Omura Breakdown of academic impact, for papers by Giuseppe Badalamenti Breakdown of academic impact, for papers by Samantha Pozzi Breakdown of academic impact, for papers by Re G Breakdown of academic impact, for papers by Annette Fisseler‐Eckhoff Breakdown of academic impact, for papers by B. Massidda Breakdown of academic impact, for papers by Beyhan Ataseven
Rankless by CCL
2026